Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Pfister C, Gravis G, Flechon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulie M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Lancet Oncol. 2024 Feb;25(2):255-264. doi: 10.1016/S1470-2045(23)00587-9. Epub 2023 Dec 21. Lancet Oncol. 2024. PMID: 38142702 Clinical Trial.
Plasma Polymerization of Precipitated Silica for Tire Application.
Kim S, Dierkes WK, Blume A, Talma A, Van Ommen JR, Courtois N, Davin J, Recker C, Schoeffel J. Kim S, et al. Among authors: davin j. Molecules. 2023 Sep 15;28(18):6646. doi: 10.3390/molecules28186646. Molecules. 2023. PMID: 37764421 Free PMC article.
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
Orlando V, Drubay D, Lavaud P, Faivre L, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houede N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon A, Grosse-Goupil M, Cojean-Zelek I, Oudard S, Labourey JL, Chinet-Charrot P, Legouffe E, Lagrange JL, Linassier C, Deplanque G, Beuzeboc P, Davin JL, Martin AL, Brihoum M, Culine S, Teuff GL, Fizazi K. Orlando V, et al. Among authors: davin jl. Clin Genitourin Cancer. 2023 Oct;21(5):615.e1-615.e8. doi: 10.1016/j.clgc.2023.05.003. Epub 2023 May 7. Clin Genitourin Cancer. 2023. PMID: 37263910 Clinical Trial.
Effect of a cervical collar on head and neck acceleration profiles during emergency spinal immobilisation and extrication procedures in elite football (soccer) players: protocol for a randomised, controlled cross-over trial.
Callaghan MJ, Hughes T, Davin J, Hayes R, Hough N, Torpey D, Perry D, Dawson S, Murray E, Jones RK. Callaghan MJ, et al. Among authors: davin j. BMJ Open Sport Exerc Med. 2021 Dec 27;7(4):e001157. doi: 10.1136/bmjsem-2021-001157. eCollection 2021. BMJ Open Sport Exerc Med. 2021. PMID: 35028158 Free PMC article.
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial.
Pfister C, Harter V, Allory Y, Radvanyi F, Culine S; VESPER Trial Investigators. Pfister C, et al. Contemp Clin Trials Commun. 2020 Jan 30;17:100536. doi: 10.1016/j.conctc.2020.100536. eCollection 2020 Mar. Contemp Clin Trials Commun. 2020. PMID: 32083220 Free PMC article.
[The REVELA13 observatory to study new cases of bladder tumor among women living in Bouches-du-Rhône county].
Martin T, Mantey K, Boissier R, Albert P, Grisoni V, Lechevallier E, Barriol D, Gravis G, Pignot G, Rossi D, Lorca J, Rattier C, Eghazarian C, Daou N, Davin JL, Clément C, Akiki A, Pascal L, Karsenty G. Martin T, et al. Among authors: davin jl. Prog Urol. 2018 Dec;28(16):935-941. doi: 10.1016/j.purol.2018.09.004. Epub 2018 Oct 10. Prog Urol. 2018. PMID: 30316672 French.
A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC; all members of the Levamisole Study Group. Gruppen MP, et al. Among authors: davin jc. Kidney Int. 2018 Feb;93(2):510-518. doi: 10.1016/j.kint.2017.08.011. Epub 2017 Oct 18. Kidney Int. 2018. PMID: 29054532 Free article. Clinical Trial.
237 results